Literature DB >> 15866568

Preimplantation genetic diagnosis: technological promise and ethical perils.

Sigal Klipstein1.   

Abstract

OBJECTIVE: To describe the ethical issues inherent to the current and foreseeable uses of preimplantation genetic diagnosis (PGD).
DESIGN: Review of ethical principles and their application to PGD.
SETTING: Academic medical center. PATIENT(S): None. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): A discussion of the current ethical perils surrounding the use of PGD, and a prediction of future ethical quandaries that will arise from the use of this technology. RESULT(S): Although PGD may be used to predict and prevent disease, it may also be used to determine nondisease traits. The ever-expanding ability of genetics to determine qualities of the preimplantation embryo continues to open up new ethical questions relating to the use of PGD for preimplantation diagnosis. CONCLUSION(S): Preimplantation genetic diagnosis is a powerful technique with many positive applications. As with all such new technologies, care should be taken to ponder the ethical implications of its use before routinely accepting PGD as a tool in the reproductive armamentarium.

Entities:  

Mesh:

Year:  2005        PMID: 15866568     DOI: 10.1016/j.fertnstert.2004.11.050

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Preimplantation genetic diagnosis: does age of onset matter (anymore)?

Authors:  Timothy Krahn
Journal:  Med Health Care Philos       Date:  2008-11-01

2.  Genetic diagnosis of embryos: clear explanation, not rhetoric, is needed.

Authors:  Chantal Bouffard; Stéphane Viville; Bartha Maria Knoppers
Journal:  CMAJ       Date:  2009-08-17       Impact factor: 8.262

3.  The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: initial findings from a grounded theory study.

Authors:  Patricia E Hershberger; Agatha M Gallo; Karen Kavanaugh; Ellen Olshansky; Alan Schwartz; Ilan Tur-Kaspa
Journal:  Soc Sci Med       Date:  2012-03-07       Impact factor: 4.634

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.